Orally administered CCR2 selective inhibitor CCX872-b clinical trial in pancreatic cancer.
暂无分享，去创建一个
S. Sleijfer | A. Hezel | T. Schall | F. Erdkamp | I. Charo | S. Miao | P. Bekker | D. Linehan | Rajinder Singh | J. Wilmink | F. Eskens | I. Desar | M. Noel | A. Wang-Gillam | Deng Jun | J. Diehl | A. Potarca | N. Zhao | Lisa K. Lohr